Principal Financial Group PFG

Financial Services · Asset Management · Synthos Deep Dive · 2026-07-03

$111.41

Buy — Tactical

—

The Overview

Principal Financial Group is a big, old (founded 1879) money-and-benefits company based in Des Moines. It does three main things: (1) runs retirement plans — the 401(k) at your job might be with Principal; (2) manages investments for big institutions and savers ($770 billion of other people's money); and (3) sells workplace benefits and life insurance — dental, disability, group life. It earns fees on the assets it manages and premiums on the insurance it writes.

Is the stock cheap or expensive? Cheap-ish. You're paying roughly 11–12 times next year's operating profit-per-share, and you collect a ~2.9% dividend while you wait. That's a value price, not a hype price. The catch is that the business only grows slowly — think mid-single digits — and it's very sensitive to the stock and bond markets: when markets fall, the fees Principal earns fall too.

Our verdict is Watch. It's not broken and it's not overpriced, but there's nothing here that makes it a must-own right now — and notably, no independent experts in our library cover it, so this call rests entirely on the numbers.

Here's what our three scores mean in everyday terms:

Downside Risk 4/10 (fairly low). The balance sheet is solid (more cash than debt), the stock doesn't swing wildly, and it's cheap — so the floor is reasonably firm. The main danger is a market crash dragging its fee income down.
Growth Quality 5/10 (middle of the road). A decent, steady business, but a lot of the per-share growth comes from buying back shares rather than the business itself getting much bigger.
Exponential Potential 2/10 (low). This is a mature giant. It should keep plodding along, but it is not going to double or triple — and its growth is slowing, not accelerating.

The one big worry: a stock-and-bond-market downturn. Principal's earnings are tied to asset prices, so a bad market year hits it twice — lower fees and lower investment income.

Putting a number on it: our fair-value estimate is $123 against a current price of $111.41 — real upside if our numbers are right.

Target entry zone $98 – $111 accumulate in this band; ideal adds on a dip toward the 200-day average near $98, keeping roughly a 9% margin below our $123 base-case fair value

Our summary metrics

Downside Risk (lower = safer)4/10Moderate

Net-cash balance sheet, beta 0.90, ~12× fwd operating EPS — but fee/AUM cyclicality & rate-sensitive liabilities.

Growth Quality5/10Moderate

~12% fwd operating-EPS CAGR (much of it buybacks), ~6.6% revenue CAGR, ROE ~13%, margins grinding up — solid, not elite.

Exponential Potential2/10Low

Mid-single-digit revenue growth that is decelerating, not accelerating; a mature $24B financial with no multibagger runway.

Fair value$123 $88–$145

What does “fair value” mean?

Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.

The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.

What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)

Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.

Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.

WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.

HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.

AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.

Exponential Potential

Exponential Potential2/10Low

Mid-single-digit revenue growth that is decelerating, not accelerating; a mature $24B financial with no multibagger runway.

What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.

Deeper analysis

Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.

Check our number Market-implied growth ≈ 6%/yr This isn’t how we calculate fair value — it’s public math you can verify yourself. To justify today’s $111, earnings would have to compound roughly 6% a year for 10 years (9% discount rate). Analysts forecast ~9%/yr, so the market is pricing in LESS than what the Street expects.

Reference table

Street consensus	$102.43 (high $125 / low $85; 0 Strong Buy · 5 Buy · 14 Hold · 6 Sell → Hold) — context, not our anchor; note the stock trades ABOVE it
Valuation	15.8× trailing GAAP EPS · ~11.9× FY26E · ~10.9× FY27E operating EPS · EV/EBITDA 12.5× · P/B 2.0×
Technicals	Uptrend — $111, −1.3% off 52-wk high, above 50/200-DMA, RSI 53 (neutral), +37% 12-mo (SPY +21%)
Conviction	Low — 0 expert claims in the Synthos KB; this is a quant/fundamental call, not a panel call
Position sizing	If owned at all: small income/value satellite, ~1–2%, not a core conviction weight

What the experts actually said

No independent expert claims in the Synthos knowledge base yet for PFG — this dive is fundamentals- and technicals-driven, not panel-driven.

Price & moving averages 12 months · 50 & 200-day averages · 52-week range

Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.

Bollinger Bands 20-day average ± 2 standard deviations

The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.

RSI (14) momentum gauge · 0–100

Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 46.

MACD 12 / 26 / 9 · trend & momentum

The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.

Relative performance vs S&P 500 & its sector (XLF (sector)), set to 100 a year ago

Solid = PFG · dashed = S&P 500 · dotted = XLF (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.

Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate

Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.

Key stats an RIA wants

Price$111.41

Market cap$24B

P/E trailing16×

P/E FY26E / FY27E12× / 11×

EV / Sales1.5×

EV / EBITDA12.1×

Gross margin48.5%

Net margin9.9%

Dividend yield2.86%

Beta0.88

52-wk range$78 – $115

RSI(14)39

50 / 200-DMA$112 / $98

12-mo return+38% (SPY +19%)

Street target$106 ($92–$125)

Analyst grades5 Buy · 14 Hold · 6 Sell

FMP ratingB+

Next earnings2026-07-27 (Q2'26 earnings; Street EPS est $2.34, revenue ~$4.13B)

1. What it is

Principal Financial Group (Nasdaq: PFG) is a diversified financial-services holding company built around three engines, run under CEO Deanna Strable (Chair, President & CEO). Fiscal year ends December 31.

Retirement and Income Solutions (RIS) — recordkeeping and products for workplace retirement savings (401(k)-type plans) and retirement income. The largest segment.
Principal Asset Management (Investment Management + International Pension) — global institutional, retail and high-net-worth asset management; $770B AUM inside $1.8T AUA (Q1'26). Includes a fast-growing International Pension book (record $160B AUM, +20% YoY).
Benefits and Protection (Specialty Benefits + Life Insurance) — group dental/disability/life and individual life.

Revenue mix (FY2025, FMP product segmentation). The FMP labels are messy and shift year to year, but the FY25 split is roughly: Retirement & Investor Services $8.18B, Benefits and Protection $4.97B, Principal Asset Management $2.81B, Corporate $0.33B. The revenue base is US-centric, with a meaningful and growing international-pension footprint (Latin America / Asia JVs). Geographic segmentation is not cleanly broken out in the current FMP feed (only legacy 2011–2013 US-insurance lines appear), so we do not over-read it.

The honest framing of the P&L. PFG's GAAP results are noisy — insurance and variable-annuity accounting (market-risk-benefit remeasurement, actuarial assumption updates) can swing a quarter hard (Q1'25 GAAP EPS was $0.21; Q3'24 printed a GAAP loss). The number management and the Street actually underwrite on is non-GAAP operating earnings: $2.17/sh in Q1'26 ex-significant-variances, +13% YoY, roughly $8.30 TTM. We use that operating series for valuation and flag it as such throughout.

2. The expert thesis — why the panel is bullish (traceable)

There is no expert coverage for PFG in the Synthos knowledge base. total_claims = 0; there are zero net-bullish and zero cautionary voices on file. There are therefore no claim_id values to cite, and we will not manufacture any — fabricated conviction is the one thing this product refuses to do.

What that means for the reader: every judgment in this note is fundamentals- and quant-driven, built from the FMP financials, analyst estimates, the SEC 8-K earnings release, and the price/technical block. Treat the conviction rating as Low accordingly. A name with no independent expert corroboration gets no conviction premium from us — the verdict has to stand on the numbers alone, and here the numbers say fine, cheap, slow rather than own it.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):

Score	0–10	The read
Downside Risk (lower = safer)	4 · Low-Moderate	Net cash (net-debt/EBITDA −0.06×), beta 0.90, tiny drawdown (−1.3% off high), ~12× fwd operating EPS. Offsets: fee/AUM cyclicality, rate-sensitive insurance liabilities, GAAP actuarial noise.
Growth Quality	5 · Moderate	~12% fwd operating-EPS CAGR — but a big slice is buybacks; revenue CAGR only ~6.6%; ROE ~13% (solid) yet ROA/ROIC thin; margins grinding higher across all four segments. Durable, not elite.
Exponential Potential	2 · Low	Mid-single-digit revenue growth that is decelerating, a mature $24B cap, and a moat (retirement recordkeeping + asset management) that is defensible but commoditizing on fees. No multibagger runway.

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them. All EPS figures are non-GAAP operating EPS (the series the Street models), labeled as estimates.

Case	Key assumptions	Fair value
Bull	Equity/credit markets stay firm → AUM and fee income compound; International Pension keeps +15–20%; Specialty Benefits loss ratios stay benign; buyback shrinks share count faster. FY27E operating EPS beats to ~$10.75 (vs ~$10.21 cons); modest re-rate to ~13.5×.	~$145 (+31%)
Base (our anchor)	Estimates roughly hit — FY27E operating EPS ~$10.21; a steady ~10–12% operating-EPS compounder with a 2.9% yield earns a fair ~12×.	~$123 (+11%)
Bear	A market drawdown cuts AUM/fee income; rate/actuarial remeasurement hits a quarter or two; sales slow. FY27E operating EPS misses to ~$9.3; multiple de-rates to ~9.5×.	~$88 (−21%)

Synthos fair value = the base case, ~$123 (+11%), with the full $88–$145 span as the honest range. This anchor sits above the Street's $102.43 consensus — and here's the tension worth naming: PFG already trades at $110.87, above the Street's own average price target. We are more constructive than the sell-side because we give more weight to the forward operating-earnings power and the buyback, but a +11% base return with no expert corroboration is a Watch, not a Buy. This is a tracked call — the Forecaster Scorecard grades it once it matures.

4. Exponential Potential

Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). PFG is neither an exponential nor even a high-octane compounder — it is a mature, cyclical cash-return story:

Forward growth: revenue CAGR FY25→FY29E ~6.6% ($15.7B → $20.3B); operating-EPS CAGR ~12% ($8.30 → $13.05) — but note the gap between the two is largely share-count reduction (buybacks) and margin creep, not organic top-line acceleration.
Acceleration (the 2nd derivative) is negative-to-flat: revenue is decelerating off post-2022 levels (FY24 $16.1B → FY25 $15.6B was actually a decline; growth resumes only modestly from here). There is no inflection to ride.
Room to run: the retirement/asset-management TAM is large but mature and fee-competitive (passive/ETF pressure on active management economics). At a $24B cap the issue isn't the law of large numbers — it's that the end markets themselves grow slowly and the fee rate is under structural pressure.
Reinvestment runway: capital is returned, not reinvested for hypergrowth — ~$0.9B buyback + ~$0.68B dividends in FY25. That's the right policy for this business, but it is the opposite of an exponential-reinvestment profile.

Exponential Potential: Low (2/10). Own PFG for yield, value, and steady mid-single-digit compounding if you own it at all — never for a fast multibagger. This honest framing is why PFG lands in a possible income/value satellite sleeve, not any conviction or "next-exponential" bucket.

5. Financials (real numbers — FMP annual/quarterly + SEC 8-K)

Revenue: FY25 $15.63B (−3.1% vs FY24 $16.13B); FY24 was +18% on FY23 $13.67B. The GAAP top line is lumpy because of insurance-line accounting — do not read it as a clean growth series.
GAAP earnings: FY25 net income $1.19B, diluted EPS $5.25 (down from FY24 $6.68 on lower realized gains / mix). GAAP is volatile; Q1'25 EPS was $0.21, Q3'24 was a loss.
Operating earnings (the real tell): Q1'26 non-GAAP operating EPS $2.07 reported / $2.17 ex-variances, +13–14% YoY; TTM operating earnings ~$1.9B. This is the series that grows steadily.
Margins & returns: net profit margin ~10% TTM, ROE ~13.3%, ROA thin (~0.5%, normal for a balance-sheet-heavy insurer/asset-manager). Segment operating margins are rising: RIS 40.2%, Investment Management 30.0%, International Pension 49.3%, Specialty Benefits 15.9% (loss ratio improved to 58.5%).
Cash flow: FY25 operating cash flow $4.54B, capex only −$98M → FCF ~$4.44B (FCF yield ~15% on market cap — flattered by insurance float dynamics, but genuinely cash-generative).
Balance sheet: total debt $3.95B against $4.43B cash → net cash (net debt −$0.48B); net-debt/EBITDA −0.06×; $1.45B excess & available capital per the 8-K. Investment-grade, well-capitalized.
AUM/AUA: $770B AUM inside $1.8T AUA, +7–8% YoY; AUM net cash flow was still slightly negative (−$1.5B in Q1'26, improving from −$4.4B) — an outflow watch item.

6. Valuation — priced in or room?

PFG screens genuinely cheap on operating earnings: ~11.9× FY26E and ~10.9× FY27E operating EPS, 12.5× EV/EBITDA, 2.0× book, with a 2.9% dividend and a ~15% (float-flattered) FCF yield. On trailing GAAP EPS it's 15.8×, but the GAAP number understates run-rate earnings power because of the actuarial noise. The FMP letter rating is B+ (overall score 3/5) — middling, consistent with "fairly valued, unspectacular."

The honest tension is the price-vs-target gap: at $110.87 the stock trades above the Street's $102.43 average target and above the $107 median, and the analyst tally is 0 Strong Buy / 5 Buy / 14 Hold / 6 Sell → Hold. So the market has already re-rated PFG toward the top of the sell-side's range. Our ~$123 base sits above consensus because we credit the forward operating-EPS path and the buyback more than the median analyst does — but we are not pounding the table on an 11% base return for a slow grower with no expert corroboration. Cheap-but-slow, fairly-to-slightly-under-valued — a value/income holding, not a growth buy.

7. Technicals (computed from EOD price history)

Trend: up. $110.87 sits above the 50-DMA ($104.19) and 200-DMA ($91.96), and the 50 is above the 200 (golden-cross posture). MACD +1.53 (positive).
Location: just −1.3% off the 52-week high ($112.36), +46.8% off the 52-week low ($75.53) — a name pressing recent highs, with a trivial max drawdown from peak (−1.3%).
Momentum: RSI(14) 52.8 — neutral, neither overbought nor oversold; no stretched-entry signal, no capitulation signal.
Relative strength: PFG +37.2% 12-mo vs SPY +20.6% and QQQ +30.3%; +23.1% 3-mo vs SPY +13.7%. It has quietly outperformed — a value name that's had a good run.
Read: technicals are constructive but the price has already done work — it's near the high, above the Street target, RSI neutral. There's no technical urgency to chase; a pullback toward the rising 50-DMA (~$104) would be a lower-risk entry for an income buyer.

8. Moat & competitive position

PFG's moat is moderate and defensive, not wide: (1) retirement recordkeeping scale and stickiness — plan sponsors don't switch 401(k) providers casually, giving RIS durable, annuity-like fee revenue; (2) a global asset-management franchise with a genuinely strong, fast-growing International Pension book (LatAm/Asia JVs, +20% AUM); (3) integrated benefits + retirement cross-sell into the SMB employer market. The countervailing force is structural fee compression in active asset management (passive/ETF substitution) and the fact that retirement recordkeeping is a scale-and-price game. This is a franchise that defends its base well but does not obviously widen its lead.

Peer set (FMP peers, market cap). Note FMP's peer list skews toward mid-cap insurers/financials rather than pure asset managers: Regions Financial $25.8B, KeyCorp $24.8B, Loews $24.0B, Everest Group $14.7B, Unum $14.8B, Brookfield Wealth Solutions $14.4B, Corebridge Financial $13.4B, Aegon $13.0B, Equitable Holdings $12.4B, Fidelity National Financial $13.1B. Against true retirement/asset-manager comps (not in this list), PFG's diversified retirement+AM+benefits mix is more defensive than a pure active manager but lower-growth than the fast-scaling alternatives managers.

9. Management, capital allocation & guidance

Capital allocation: shareholder-return-first, appropriately for a mature financial. FY25 returned ~$0.9B via buyback and ~$0.68B via dividend; Q1'26 returned $374M ($200M repurchase + $174M dividend). The Board raised the dividend 8% to $0.82/qtr (Q2'26). Net-cash balance sheet, $1.45B excess & available capital. This is disciplined and consistent.
Insider activity: the recent Form 4s (2026-06-26 filings) are routine director equity awards (A-Award, grant-type, price $0), not open-market buying or selling — no signal either way.
Management's own guidance (half-weighted — their own book). Per the Q1'26 earnings release (SEC 8-K, filed 2026-04-23), CEO Deanna Strable framed the quarter around "strong revenue growth, EPS growth and ROE expansion" driven by "a sharp focus on higher growth markets," and said the company is "confident in the strength of our diversified, integrated portfolio" entering 2Q26, emphasizing "disciplined risk management and focused growth investments." Concrete, dated data points from that release: operating EPS ex-variances +13% YoY; RIS transfer deposits +35%; Investment Management gross sales +21%; International Pension AUM +20%; Specialty Benefits sales +24%; AUM $770B. The release gave no explicit full-year numerical EPS/revenue guidance range — Principal guides qualitatively (growth-market focus, capital return) rather than to a hard EPS target. We label all of the above as management's self-interested words, half-weighted, and note the absence of a hard guide.

10. Catalysts & what to watch

Next earnings: 2026-07-27 (Q2'26; Street EPS $2.34, revenue ~$4.13B). Key lines: operating EPS trajectory, AUM net flows (are outflows turning positive?), and Specialty Benefits loss ratio.
AUM net cash flow: still slightly negative (−$1.5B Q1'26); a flip to sustained positive net flows is the single biggest fundamental swing factor for the fee engine.
Equity/credit markets: PFG's fee and spread income track asset prices — a market drawdown is the fastest way to miss estimates.
International Pension: the +20% AUM grower and the most attractive part of the story; watch for continued momentum and FX effects (recent FX tailwinds helped).
Capital return: buyback pace and further dividend action — the core of the total-return thesis.

Thesis tripwires (what would change the call): two consecutive quarters of accelerating AUM outflows; a Specialty Benefits loss-ratio deterioration above target; operating-EPS growth stalling below mid-single digits; or a market drawdown that compresses fee income materially.

11. Key risks

Market / AUM cyclicality (structural): fees and spread income fall with equity and bond markets — the dominant risk. A bad market year hits both fee revenue and investment income.
GAAP / actuarial volatility: insurance and variable-annuity accounting (market-risk-benefit remeasurement, assumption updates) can whipsaw reported EPS quarter to quarter (Q1'25 $0.21, Q3'24 a GAAP loss).
Fee compression: structural passive/ETF pressure on active asset-management economics erodes the AM fee rate over time.
Interest-rate sensitivity: rate moves affect spread-based products, reinvestment yields, and the value of the insurance liability book.
Valuation-vs-target gap: the stock already trades above the Street's average price target with a Hold consensus — limited sell-side "catch-up" fuel from here.
No expert corroboration: zero Synthos KB coverage means no independent panel is validating a bull thesis; the call rests entirely on the quant/fundamental read.

12. Verdict, position sizing & monitoring

Watch. Principal is a cheap (~11–12× forward operating EPS), well-capitalized (net cash, $1.45B excess capital), shareholder-friendly (2.9% yield, rising dividend, steady buyback) financial with a genuinely attractive International Pension grower inside an otherwise mature, fee-pressured, cyclical franchise. The problem for a Buy rating is threefold: growth is mid-single-digit and decelerating, the stock already trades above the Street's own price target with a Hold consensus, and there is zero expert coverage in our KB to lend conviction. The problem for an Avoid is that none of that is broken — the balance sheet is sound, the cash return is real, and the base case is still modestly positive (+11%). That balance is precisely a Watch.

Sizing: if owned, a small income/value satellite, ~1–2% — not a core conviction weight. Best entered on weakness toward the ~$104 50-DMA rather than chased near the 52-week high.
Monitoring: re-underwrite on the tripwires in §10; formal re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $110.87.
Single biggest risk: a market/AUM drawdown that drags fee and spread income down — the earnings stream is only as steady as asset prices allow.

Provenance & disclosures

Traceability: 0 KB claims, breadth 0 — there is no expert coverage for PFG in the Synthos knowledge base, so no claim_ids are cited and none were invented. This note is explicitly fundamentals- and quant-driven, and the conviction rating is Low by construction.
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · management guidance from the SEC 8-K earnings release filed 2026-04-23. Forward figures are analyst consensus (FMP) or our own scenario model, labeled as estimates; EPS figures in §3/§5 are non-GAAP operating EPS where noted.
Management caveat: the §9 guidance is management's own book, half-weighted by design, and Principal issues only qualitative (not hard-numerical) forward guidance.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").